Alexander M. Klibanov
Novartis Professor of Chemistry and Bioengineering
areas of expertise: biochemistry in nonaqueous media, enzymes as catalysts in organic chemistry, stability, stabilization, and formulation of pharmaceutical proteins, antimicrobial materials, drug delivery, biomolecular engineering, antiviral drugs, bionanotechnology, chemistry
Alexander Klibanov received his MS in chemistry in 1971 and PhD in chemical enzymology in 1974 from Moscow University in Russia. Following his emigration to the United States in 1977, he spent two years as a postdoctoral associate at the chemistry department of the University of California, San Diego. In 1979, Klibanov joined the faculty at MIT, where he is a Novartis Endowed Chair Professor of Chemistry and Bioengineering.
His current research interests include medicinal chemistry, enzymes biotechnology; drug delivery, stabilization, and formulations; new antiviral preparations; and new microbicidal materials. Klibanov has authored more than 270 scientific papers and 16 issued U.S. patents, has given 360-plus presentations, including many named lectures all over the world, and is a member of eight journal editorial boards. He has received numerous prestigious professional awards, including the Leo Friend Award, the Ipatieff Prize, the Marvin J. Johnson Award, and the Arthur C. Cope Scholar Award, all from the American Chemical Society, as well as the International Enzyme Engineering Prize. He was elected to the National Academy of Sciences and to the National Academy of Engineering of the United States.
In addition, Klibanov has started five biotechnology companies and has been a scientific advisor/consultant for numerous biotechnology, pharmaceutical and chemical companies, as well as for law firms in various intellectual property litigations.
request an interview: Sarah McDonnell | 617-253-8923 | email@example.com